Helping companies around the world commercialize the revolutionary research done at Georgia Tech
Dr. Lieberman’s research group studies the molecular aspects of protein misfolding to understand its impact on human disease and develop research tools that can lead to new discoveries, therapeutics, and diagnostic tools.
Dr. Julie Champion’s lab focuses on designing proteins that enable the delivery of large molecules into cells for human therapeutics.
Dr. Dasi’s research is focused on heart valve pre-surgical planning using artificial intelligence (AI) software that predicts the heart’s physical interaction with implanted devices and its implications on complications, outcomes, and lifetime management.